Publikationen von A. Erhardt
Alle Typen
Konferenzbeitrag (7)
2017
Konferenzbeitrag
27 (Suppl. 4), S.08.02, S. S534 - S534 (2017)
Candidate genes involved in the aetiology and therapy response in panic disorder. 30th Congress of the European College of Neuropsychopharmacology (ECNP), Paris, FRANCE, 02. September 2017 - 05. September 2017. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Konferenzbeitrag
27 (Suppl.2), Su19, S. S217 - S218 (2017)
GENOME-WIDE ASSOCIATION STUDY OF PANIC DISORDER. 23rd Annual World Congress of Psychiatric Genetics (WCPG), Toronto, CANADA, 16. Oktober 2015 - 20. Oktober 2015. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Konferenzbeitrag
27 (Suppl. 2), Sa22, S. S160 - S160 (2017)
ASSOCIATION BETWEEN GENES ON CHROMOSOME 19P32.2 AND PANIC DISORDER. 23rd Annual World Congress of Psychiatric Genetics (WCPG), Toronto, CANADA, 16. Oktober 2015 - 20. Oktober 2015. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Konferenzbeitrag
27 (Suppl. 3), T24, S. S446 - S447 (2017)
SEX-SPECIFIC DNA METHYLATION SIGNATURES IN PANIC DISORDER. 24th World Congress of Psychiatric Genetics (WCPG), Jerusalem, ISRAEL, 30. Oktober 2016 - 04. November 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Konferenzbeitrag
27 (Suppl. 2), Su48, S. S231 - S231 (2017)
EPIGENOME-WIDE ASSOCIATION STUDY (EWAS) IN A PANIC DISORDER COHORT. 23rd Annual World Congress of Psychiatric Genetics (WCPG), Toronto, CANADA, 16. Oktober 2015 - 20. Oktober 2015. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Konferenzbeitrag
124 (10), 150, S. 1295 - 1295 (2017)
The neural correlates of fear generalization and its moderation by genetically determined risk for panic disorder. Conference of the World-Association-for-Stress-Related-and-Anxiety-Disorders (WASAD), Würzburg, GERMANY, 14. September 2017 - 16. September 2017. JOURNAL OF NEURAL TRANSMISSION
Konferenzbeitrag
27 (Suppl. 3), S. S502 - S502 (2017)
GENOME-WIDE ASSOCIATION STUDY OF PANIC DISORDER. 24th World Congress of Psychiatric Genetics (WCPG), Jerusalem, ISRAEL, 30. Oktober 2016 - 04. November 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY Meeting Abstract (6)
2022
Meeting Abstract
63, S. E101 - E101. (2022)
GENOME-WIDE ANALYSIS IDENTIFIES SORCS3 AS A NOVEL SUSCEPTIBILITY LOCUS FOR PANIC DISORDER IN THE FINNGEN STUDY. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021
Meeting Abstract
128 (11), S. 1798 - 1798. (2021)
Stress-induced changes in DNA-methylation: focus on anxiety disorders. In JOURNAL OF NEURAL TRANSMISSION, 2019
Meeting Abstract
126 (11), S. 1564 - 1565. International Congress of the
World-Association-for-Stress-Related-and-Anxiety-Disorders (WASAD), Wurzburg, GERMANY, 03. Oktober 2019 - 05. Oktober 2019. Springer-Verlag., Wien (2019)
Genetics and epigenetics of panic disorder. In Journal of Neural Transmission,
Meeting Abstract
29, S. S776 - S776. 25th World Congress of Psychiatric Genetics (WCPG), Orlando, FL, 13. Oktober 2017 - 17. Oktober 2017. Elsevier, Amsterdam (2019)
Genome-wide association study of panic disorder. In European Neuropsychopharmacology,
Meeting Abstract
29, S. S776 - S776. 25th World Congress of Psychiatric Genetics (WCPG), Orlando, FL, 13. Oktober 2017 - 17. Oktober 2017. (2019)
GENOME-WIDE ASSOCIATION STUDY OF PANIC DISORDER. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014
Meeting Abstract
17, RA-01-003, S. 42 - 42. 29th CINP World Congress of Neuropsychopharmacology
, Vancouver, Canada, 22. Juni 2014 - 26. Juni 2014. Oxford University Press, Oxford, UK (2014)
Genetic predictor of antidepressant response for major depressive disorder accounting for clinical subgroups: A genome-wide association study. In INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, Hochschulschrift - Doktorarbeit (1)
2003
Hochschulschrift - Doktorarbeit
Einfluß der repetitiven transkraniellen Magnetstimulation (rTMS) auf das mesolimbische dopaminerge System bei drogennaiven und morphinvorbehandelten Ratten. Dissertation, Ludwig-Maximillians-Universität, München (2003)
Rezension (2)
2021
Rezension
The role of pharmacogenetics in the treatment of anxiety disorders and the future potential for targeted therapeutics. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)
2019
Rezension
32 (1), S. 1 - 6 (2019)
Predicting treatment outcome for anxiety disorders with or without comorbid depression using clinical, imaging and (epi) genetic data. CURRENT OPINION IN PSYCHIATRY